Watchdog fines Pfizer and Flynn £70m for overcharging NHS for epilepsy drug - The Guardian

Penalties come after an in-depth investigation carried out by the Competition and Markets Authority

The drugmakers Pfizer and Flynn Pharma have been fined a total of £70m for overcharging the NHS for a life-saving epilepsy drug. The UKs competition watchdog fined New York-based Pfizer £63m and imp… [+3116 chars]

full article...